The specialty pharmaceutical company develops, manufactures and markets a range of pharmaceutical products.
Valeant chairman and CEO Michael Pearson said the company had a strong Canadian presence always and expect to continue to increase the activities here in Canada.
"Our vision is no less than to become the world leader in the dermatology sector and our commitment is to achieve this here from our base in Quebec, one of our centers for dermatology development," Pearson added.
The company believes that establishment of its international headquarters in the Montreal region provides tangible benefits for Quebec and its economy.